OPTREX BLOODSHOT Eye drops Ref.[8107] Active ingredients: Naphazoline

Not to be used by contact lens wearers whilst wearing lenses.

If you are being treated for high blood pressure, depression, heart disease, diabetes or increased thyroid activity consult your doctor before using the drops.

Discard any eye drops remaining 28 days after opening the container.

Continued use of this product may increase redness of the eye.

If you experience eye pain, changes in vision or continued redness of the eye, or if the condition worsens or persists for more than 24 hours consult a doctor.

If you have any eye disease, suffer from glaucoma or have had eye surgery, do not use this product except under the advice and supervision of a doctor.

If the solution changes colour or becomes cloudy do not use.

May interact with other topically applied autonomic drugs used in the treatment of glaucoma. May interact with monoamine oxidase inhibitors and should not be used by patients receiving such treatment or within 14 days of ceasing therapy. May reverse the antihypertensive action of drugs used in the treatment of hypertension. There may be an increased risk of arrhythmias in patients receiving cardiac glycosides, quinidine or tricyclic antidepressants.

Although the safety of Optrex Red Eyes Eye Drops during pregnancy and lactation has not been established, it is unlikely that sufficient of the active ingredients will reach the foetus or the breast-fed infant to be harmful.

Not applicable.

Transient irritation and stinging may occur. Following long term use a rebound secondary hyperaemia may occur.

Not applicable.